Health · 1 views
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S.
Source Medical Xpress AI Summary Updated 1h 47m ago
Story intelligence Beta
Freshness Fresh Updated 1h 47m ago
Confidence Limited Single-outlet story
Coverage Single outlet
Views 1 Community interest
Read time 1 min ~41 words
AI Summary
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in marijuana—THC and CBD—had significantly less agitation than people who received a placebo.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage